Generic Name |
Imatinib + Atezolizumab | |
---|---|---|
IND |
||
Brand Name (US) |
||
Manufacturer |
||
Drug Type |
||
Delivery |
Oral and intravenous | |
Approval Status |
||
Indications |
||
Overall Strategy |
KIT Protein and immune system | |
Strategy |
Block KIT + Unblock cell death genes | |
Drug Category |
KIT/PDGFRA inhibitor + PD-L1 inhibitor |